These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30925610)

  • 41. Behavioural problems associated with dementia: the role of newer antipsychotics.
    Stoppe G; Brandt CA; Staedt JH
    Drugs Aging; 1999 Jan; 14(1):41-54. PubMed ID: 10069407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An individualized psychosocial approach for "treatment resistant" behavioral symptoms of dementia among aged care residents.
    Davison TE; Hudgson C; McCabe MP; George K; Buchanan G
    Int Psychogeriatr; 2007 Oct; 19(5):859-73. PubMed ID: 16973098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The efficacy of multi-sensory environment therapy on psychological, behavioral symptoms among elderly patients with dementia].
    Wang YY; Chiu CH; Chen YY; Lee KH; Sun HF
    Hu Li Za Zhi; 2011 Feb; 58(1):48-58. PubMed ID: 21328205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias.
    Huang TY; Wei YJ; Moyo P; Harris I; Lucas JA; Simoni-Wastila L
    J Am Geriatr Soc; 2015 Sep; 63(9):1757-65. PubMed ID: 26310959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761.
    Hoerr R
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S56-61. PubMed ID: 13130390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A nondrug approach to dementia.
    Raetz J
    J Fam Pract; 2013 Oct; 62(10):548-57. PubMed ID: 24143346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive Remediation Therapy for Psychotic Major Depressive Disorder.
    Allan S; Cella M; Wykes T; Perez J
    Prim Care Companion CNS Disord; 2018 Jun; 20(3):. PubMed ID: 29902368
    [No Abstract]   [Full Text] [Related]  

  • 48. Can cognitive remediation improve subsequent response to low-intensity cognitive behaviour therapy for psychosis in people with schizophrenia?
    Naeem F
    Aust N Z J Psychiatry; 2017 Feb; 51(2):117-118. PubMed ID: 27920065
    [No Abstract]   [Full Text] [Related]  

  • 49. The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials.
    Kurz AF; Leucht S; Lautenschlager NT
    Int Psychogeriatr; 2011 Nov; 23(9):1364-75. PubMed ID: 21740614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias.
    Morhardt D; Weintraub S; Khayum B; Robinson J; Medina J; O'Hara M; Mesulam M; Rogalski EJ
    Psychiatr Clin North Am; 2015 Jun; 38(2):333-52. PubMed ID: 25998120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ECT treatment for two cases of dementia-related pathological yelling.
    Bang J; Price D; Prentice G; Campbell J
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):379-80. PubMed ID: 18806251
    [No Abstract]   [Full Text] [Related]  

  • 53. Guidelines for treating dementia-associated agitation.
    Goldsmith MF
    JAMA; 1998 Jun; 279(22):1770. PubMed ID: 9628696
    [No Abstract]   [Full Text] [Related]  

  • 54. Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors.
    Rios S; Perlman CM; Costa A; Heckman G; Hirdes JP; Mitchell L
    BMC Geriatr; 2017 Oct; 17(1):244. PubMed ID: 29061129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azelastine hydrochloride on behavioral and psychological symptoms and activities of daily living in dementia patients.
    Hatakeyama A; Fujii M; Hatakeyama R; Fukuoka Y; Satoh-Nakagawa T; Sasaki H
    Geriatr Gerontol Int; 2008 Mar; 8(1):59-61. PubMed ID: 18713191
    [No Abstract]   [Full Text] [Related]  

  • 56. Cognitive intervention for early stage dementia: Research and techniques.
    DenBoer JW
    Appl Neuropsychol Adult; 2018; 25(6):562-571. PubMed ID: 28880690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of human cognitive neuroscience in drug discovery for the dementias.
    Wesnes KA; Edgar CJ
    Curr Opin Pharmacol; 2014 Feb; 14():62-73. PubMed ID: 24565014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ward based management of behavioural and psychological symptoms of dementia.
    Nguyen J; Ko I; Martinez-Sosa S; Mizoguchi R
    BMJ; 2021 Aug; 374():n1779. PubMed ID: 34348927
    [No Abstract]   [Full Text] [Related]  

  • 59. A randomized controlled trial for an individualized positive psychosocial intervention for the affective and behavioral symptoms of dementia in nursing home residents.
    Van Haitsma KS; Curyto K; Abbott KM; Towsley GL; Spector A; Kleban M
    J Gerontol B Psychol Sci Soc Sci; 2015 Jan; 70(1):35-45. PubMed ID: 24304555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia.
    Dyer SM; Harrison SL; Laver K; Whitehead C; Crotty M
    Int Psychogeriatr; 2018 Mar; 30(3):295-309. PubMed ID: 29143695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.